Greater Cannabis Company (GCAN) Return on Capital Employed (2018 - 2026)

Greater Cannabis Company's (GCAN) quarterly Return on Capital Employed came in at 22.29% in Q1 2026, up 549.0% year-on-year from 3.43% in Q1 2025, and down 10.91% quarter-over-quarter from 25.02% in Q4 2025.

Greater Cannabis Company (GCAN) Return on Capital Employed (2018 - 2026) Analysis & Trends

Greater Cannabis Company's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 22.29% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 549.0% year-over-year to 22.29% in Q1 2026; TTM through Mar 2026 was 22.29%, a 549.0% increase from a year earlier, with the FY2025 full-year figure at 25.66%, up 570.0% from the prior year.
  • Return on Capital Employed retreated to 22.29% in Q1 2026 per GCAN's latest filing, from 25.02% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 48.98% in Q1 2022 and bottomed at 15.09% in Q3 2025.
  • The 5-year median for Return on Capital Employed is 25.47% (2024), against an average of 27.67%.
  • Across the five-year window, Return on Capital Employed plunged 9665 bps in 2022 and surged 636 bps in 2025, its largest moves.
  • Year by year, Return on Capital Employed stood at 33.11% in 2022, then decreased by 18 bps to 27.22% in 2023, then plunged by 31 bps to 18.67% in 2024, then soared by 34 bps to 25.02% in 2025, then declined by 11 bps to 22.29% in 2026.
  • Per Business Quant, the three latest GCAN Return on Capital Employed figures stand at 22.29% (Q1 2026), 25.02% (Q4 2025), and 15.09% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 8.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 27.36%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -1.50%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 21.43%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.46%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 20.04%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 5.24%
10 Greater Cannabis Company 292,929.85 292,929.85 - 22.29%

Historic Data

Download Data
DateValue
Mar 31, 2026 22.29%
Dec 31, 2025 25.02%
Sep 30, 2025 15.09%
Jun 30, 2025 15.99%
Mar 31, 2025 16.81%
Dec 31, 2024 18.67%
Sep 30, 2024 20.66%
Jun 30, 2024 23.80%
Mar 31, 2024 25.47%
Dec 31, 2023 27.22%
Sep 30, 2023 27.59%
Jun 30, 2023 27.51%
Mar 31, 2023 30.11%
Dec 31, 2022 33.11%
Sep 30, 2022 46.36%
Jun 30, 2022 45.67%
Mar 31, 2022 48.98%
Dec 31, 2021 83.56%
Sep 30, 2021 117.28%
Jun 30, 2021 142.32%